Background/Aims Non-alcoholic fatty liver disease (NAFLD) is widespread chronic disease
of the live in humans with the prevalence of 30% of the United States population. 1, 2 The …

Background Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver
disease worldwide. Quantitative ultrasound (QUS) parameters based on radiofrequency raw …

Background & Aims Liver biopsy analysis is the standard method used to diagnose
nonalcoholic fatty liver disease (NAFLD). Advanced magnetic resonance imaging is a …

Warszawski Uniwersytet Medyczny - Repozytorium Repository of Medical University of
Warsaw https://ppm.wum.edu.pl Polska Platform Page 1 Warszawski Uniwersytet Medyczny …

Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease from fatty accumulation
(steatosis), necro-inflammation though to fibrosis. It is of increasing global prevalence as a …

Nonalcoholic fatty liver disease is a major global health concern with increasing prevalence,
associated with obesity and metabolic syndrome. Recently, quantitative ultrasound-based …

Abstract Background & Aims Liver ultrasound (US) is usually used in the clinical setting for
the diagnosis and follow‐up of patients with nonalcoholic fatty liver disease (NAFLD) …

Background The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing in the
USA. Some of these patients develop non-alcoholic steatohepatitis (NASH), which can …

Purpose: To assess the diagnostic performances of novel Tissue attenuation imaging (TAI)
and Tissue scatter distribution imaging (TSI) tools in quantification of liver fat content using …

Prospective study comparing hepatic steatosis assessment by magnetic resonance imaging
and four ultrasound methods in 105 successive patients - PMC Back to Top Skip to main …